• Temperature-controlled logistics has become critical trade infrastructure, with cold chain performance now shaping food security, pharmaceutical resilience, regulatory trust, and cross-border competitiveness.
• Automation, digital visibility, and predictive analytics are transforming cold chains from reactive containment systems into proactive, compliance-ready networks that assure quality and reduce risk.
• As biologics and time-sensitive goods drive complexity, resilient cold chains will depend on multimodal integration, data interoperability, sustainability, and cross-industry collaboration rather than speed alone.

Temperature-controlled logistics has moved decisively from the margins of supply chains to the centre of trade policy, public health planning and air cargo strategy. As global commerce becomes more time-sensitive and quality-driven, the cold chain is emerging as critical infrastructure, on par with ports, airports and digital trade systems. For policymakers and air cargo stakeholders, its performance now shapes food security, pharmaceutical resilience and the credibility of cross-border trade itself.

This shift is being driven by a convergence of forces as the rapid growth of biologics and advanced therapies, longer and more fragmented food supply chains, and stricter regulatory expectations on traceability, emissions and product integrity. Together, they are transforming cold chain logistics from a reactive function focused on containment into a proactive, data-led system designed to manage risk, assure quality and support global trade flows.

Automation as a policy enabler

Automation is redefining how cold chains are governed and assessed. Jez Palmer, Senior Director APAC at CSafe, argued that temperature assurance must now be continuous rather than episodic. “The industry is moving from monitoring to management,” he said, pointing to the growing role of active containers, real-time sensors and predictive analytics.

This evolution has regulatory significance. Automated systems reduce dependency on manual intervention, standardise outcomes across geographies and generate auditable data trails. Palmer noted that regulators and customers increasingly expect real-time visibility, particularly for high-value pharmaceutical shipments, making digital assurance a baseline requirement rather than a competitive add-on.

Pharmaceutical supply chains and the economics of failure

In life sciences logistics, cold chain reliability is inseparable from patient safety and regulatory compliance. Rituparna Chaturvedi, Country Manager at CRYOPDP, highlighted how shrinking tolerance for temperature excursions is reshaping operational expectations. “In pharma logistics, failure is not a delay, it is a loss of product and potentially a loss of trust,” he said.

Chaturvedi noted that decentralised manufacturing, global clinical trials and direct-to-patient distribution models are stretching traditional cold chain designs. In response, logistics providers are investing in validated lanes, specialised packaging and highly trained handling teams.

Chaturvedi further asserted that, “from a policy perspective, this underscores the need for harmonised standards and predictable customs processes to prevent weak links in international pharma corridors.” 

Multimodal integration and the role of air cargo

Cold chain resilience increasingly depends on how well air cargo integrates with sea and land transport. Vishal Jaiman, Sector Head (Healthcare) at DP World’s Supply Chain Organisation, framed multimodal integration as essential to continuity rather than efficiency alone. “Cold chains cannot afford weak links,” he said. “Integration across ports, airports and inland facilities is what ensures continuity.”

Jaiman highlighted the importance of port-centric logistics parks, temperature-controlled free zones and synchronised border processes in reducing dwell times and energy loss. For air cargo networks, this reinforces the strategic role of airports as nodes within wider cold chain ecosystems rather than standalone gateways.

As trade lanes diversify, multimodal orchestration allows shippers to balance speed, cost and sustainability without compromising quality.

Manufacturers prioritise predictability over speed

From the manufacturing perspective, predictability is increasingly valued over headline transit times. Pratyush Kumar, Vice President Supply Chain at Glenmark Pharmaceuticals, explained that reliable cold chains enable more disciplined production and inventory planning. “We design our supply chains around certainty,” he said. “A predictable cold chain reduces buffers, waste and risk.”

Kumar noted that “regulatory scrutiny is pushing manufacturers to demonstrate end-to-end control, including visibility into third-party handling.” Digital platforms that integrate temperature data with shipment status are becoming essential for compliance and audit readiness.

This highlights how data interoperability and standardisation are becoming as important as physical infrastructure.

Biologics and the escalation of complexity

Advanced biologics and cell-based therapies represent the next frontier of cold chain complexity. Surendra Deodhar, Vice President and Head of Materials Management at Reliance Life Sciences, described how ultra-low temperature requirements and narrow handling windows are raising operational stakes. “The margin for error is shrinking,” he said. “Cold chains must be engineered for precision.”

These products demand specialised infrastructure, rigorous validation and highly skilled personnel at every handover point. Deodhar argued that “investment decisions should focus on long-term capability rather than short-term throughput, particularly as biologics move from niche to mainstream.” He also stressed that sustainability must be embedded into cold chain design, given the energy intensity of ultra-cold storage and transport.

Sustainability, waste reduction and trade credibility

Sustainability is no longer separable from cold chain performance. Reducing wastage, whether spoiled food or compromised medicines delivers both economic and environmental benefits. It is evident that, automation and analytics can reduce energy use by optimising routes, minimising dwell times and improving asset utilisation. Multimodal planning also enables lower-emission choices where feasible, without sacrificing quality.

Beyond emissions, efficient cold chains support broader public policy goals, from food security to equitable access to medicines. By preserving quality over longer distances, they enhance the credibility of international trade systems and reinforce trust among regulators and consumers.

Collaboration as strategic necessity

As Ryan Viegas, Consultant – Pharma & Healthcare, observed that no single actor can optimise the cold chain in isolation. Standards alignment, shared data frameworks and joint infrastructure investment are becoming essential as volumes and complexity grow. “The cold chain is an ecosystem,” he noted, requiring cooperation across industries and borders.

The global cold chain is evolving into integrated, trade-critical infrastructure. Automation delivers assurance, multimodal integration provides resilience, and collaboration underpins scalability. For air cargo and trade policy professionals, the implication is clear. Preserving quality is no longer a technical challenge but it is a strategic imperative that will shape competitiveness, compliance and public confidence in global supply chains.

The post Cold chains under the microscope appeared first on Air Cargo Week.